Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI)
ClinicalTrials.gov ID: NCT06625216; Central Ethics Committee: Comitato Etico Area Vasta Nord-Ovest Toscana (study number 1245/2016, protocol number:73714).
Authors
- Francesco Blasi (ORCID: https://orcid.org/0000-0002-2285-9970)
- Cristina Cardini (ORCID: https://orcid.org/0000-0002-7779-9370)
- Giulia Scioscia (ORCID: https://orcid.org/0000-0002-2667-077X)
- Fulvio Braido (ORCID: https://orcid.org/0000-0003-2460-4709)
- Giorgio Walter Canonica (ORCID: https://orcid.org/0000-0001-8467-2557)
- Vincenzo Bagnardi (ORCID: https://orcid.org/0000-0002-4938-3482)
- Isabella Sala (ORCID: https://orcid.org/0000-0002-4404-4537)
- Chiara Oriecuia (ORCID: https://orcid.org/0000-0002-0079-6446)
- Enrico Marco Heffler (ORCID: https://orcid.org/0000-0002-0492-5663)
- Luisa Brussino (ORCID: https://orcid.org/0000-0001-7249-7616)
- Pierluigi Paggiaro
Institutions
- University of Foggia (IT)
- University of Pisa (IT)
- Humanitas University (IT)
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- A. O. Ordine Mauriziano di Torino (IT)
- Ospedale Policlinico San Martino (IT)
- IRCCS Humanitas Research Hospital (IT)
- University of Milano-Bicocca (IT)
- University of Brescia (IT)
- University of Genoa (IT)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1016/j.waojou.2024.101016
- Citations
- 9
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Pfizer
- AstraZeneca
- Sanofi
- Chiesi Farmaceutici
- Regeneron Pharmaceuticals
- Celltrion
- Insmed
- Grifols
- Genentech
- Sanofi Genzyme